Latanoprost
FDA status: FDA has approved products that contain latanoprost, including Iyuzeh, Rocklatan, Xalatan, Xelpros.
PubMed: 2,219 publications mention Latanoprost, 516 of them trials or reviews. Search PubMed
- Comparative Effectiveness of First-Line Medications for Primary Open-Angle Glaucoma: A Systematic Review and Network Meta-analysis. Li T et al. Ophthalmology, 2016. Systematic Review, Network Meta-Analysis. PMID 26526633 · DOI
- MERCURY-3: a randomized comparison of netarsudil/latanoprost and bimatoprost/timolol in open-angle glaucoma and ocular hypertension. Stalmans I et al. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2024. Randomized Controlled Trial. PMID 37615697 · DOI
- Efficacy and safety of netarsudil/latanoprost fixed-dose combination vs. monotherapy in open-angle glaucoma or ocular hypertension: A systematic review and meta-analysis of randomized controlled trials. Luo N et al. Frontiers in medicine, 2022. Systematic Review. PMID 35979215 · DOI
- Randomized crossover study of latanoprost and travoprost in eyes with open-angle glaucoma. Sawada A et al. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2012. Randomized Controlled Trial. PMID 21858678 · DOI
- Comparative study of latanoprost (0.005%) and bimatoprost (0.03%) in primary open angle glaucoma. Kausar N et al. Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH, 2022. Randomized Controlled Trial. PMID 37609969 · DOI
ClinicalTrials.gov: 278 registered studies. See all studies
MedlinePlus drug information ↗FDA label (DailyMed) ↗RxNorm 43611 ↗PubChem CID 5311221 ↗Wikipedia ↗









